Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (460)

Latest Posts

About This Stock More About This Stock
Pfizer, Gilead Strike Multiyear Partnership To Manufacture COVID-19 Drug Remdesivir
Article By: Benzinga
Friday, August 7, 2020 10:52 AM EDT
Large-cap biopharma companies Pfizer Inc. and Gilead Sciences, Inc. announced a deal Friday for Gilead's remdesivir, which has been accorded emergency use authorization by the FDA for treating COVID-19.
In this article: PFE, GILD
Read
Stocks Are Rising On The Appearance Of Massive Earnings “Beats”
Article By: Michael J. Kramer
Friday, July 31, 2020 9:15 AM EDT
Stocks are rising following the “strong” quarterly results last night.
In this article: TCEHY, AMZN, FB, QQQ, SPY, GILD
Read
Gilead Sciences Misses Q2 Earnings And Revenue Estimates
Article By: Zacks Investment Research
Thursday, July 30, 2020 6:21 PM EDT
Gilead Sciences came out with quarterly earnings of $1.11 per share.
In this article: GILD
Read
E Market Briefing For Monday, July 13
Article By: Gene Inger
Sunday, July 12, 2020 7:30 PM EDT
The world is piling into very expensive stocks; a shakeout looms out there, though probably not yet.
In this article: JPM, GILD Also: OIL
Read
E HIV Cure Challenger CytoDyn Takes On Gilead Sciences
Article By: Moon Kil Woong
Friday, July 3, 2020 11:10 AM EDT
CytoDyn believes they have a cure for HIV that will work on a subpopulation of patients with cancer.
In this article: CYDY, GILD Also: MRK
Read

PARTNER HEADLINES

Latest Tweets for $GILD

No tweets yet!

$GILD

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

www.talkmarkets.com/.../interview-with-vitality-biopharma-inc

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments